Catechol-based matrix metalloproteinase inhibitors with additional antioxidative activity

References

• Khokha R, Murthy A, Weiss A. Metalloproteinases and their natural inhibitors in inflammation and immunity. Nat Rev Immunol 2013;13:649–65.
   PubMed Web of Science ®Google Scholar
• Vandenbroucke RE, Libert C. Is there new hope for therapeutic matrix metalloproteinase inhibition? Nat Rev Drug Discov 2014;13:904–27.
   PubMed Web of Science ®Google Scholar
• Tauro M, Laghezza A, Loiodice F, et al. Arylamino methylene bisphosphonate derivatives as bone seeking matrix metalloproteinase inhibitors. Bioorg Med Chem 2013;21:6456–65.
   PubMed Web of Science ®Google Scholar
• Rubino MT, Agamennone M, Campestre C, et al. Biphenyl sulfonylamino methyl bisphosphonic acids as inhibitors of matrix metalloproteinases and bone resorption. ChemMedChem 2011;6:1258–68.
   PubMed Web of Science ®Google Scholar
• Dufour A, Overall CM. Missing the target: matrix metalloproteinase antitargets in inflammation and cancer. Trends Pharmacol Sci 2013;34:233–42.
   PubMed Web of Science ®Google Scholar
• Tauro M, McGuire J, Lynch CC. New approaches to selectively target cancer-associated matrix metalloproteinase activity. Cancer Metastasis Rev 2014;33:1043–57.
   PubMed Web of Science ®Google Scholar
• Gupta A, Kaur CD, Jangdey M, Saraf S. Matrix metalloproteinase enzymes and their naturally derived inhibitors: novel targets in photocarcinoma therapy. Ageing Res Rev 2014;13:65–74.
   PubMed Web of Science ®Google Scholar
• Hwang KA, Yi BR, Choi KC. Molecular mechanisms and in vivo mouse models of skin aging associated with dermal matrix alterations. Lab Anim Res 2011;27:1–8.
   PubMedGoogle Scholar
• Quan T, Qin Z, Xia W, et al. Matrix-degrading metalloproteinases in photoaging. J Investig Dermatol Symp Proc 2009;14:20–4.
   PubMed Web of Science ®Google Scholar
• Yaar M, Gilchrest BA. Photoageing: mechanism, prevention and therapy. Br J Dermatol 2007;157:874–87.
   PubMed Web of Science ®Google Scholar
• Hsieh H-Y, Lee W-C, Senadi GC, et al. Discovery, synthetic methodology, and biological evaluation for antiphotoaging activity of bicyclic [1,2,3] triazoles: in vitro and in vivo studies. J Med Chem 2013;56:5422–35.
   PubMed Web of Science ®Google Scholar
• Ceccoli JD, Costello B, Hayward JA, Lahanas KM. Bath & Body Works Brand Management, Inc., USA, assignee. Topical compositions for inhibiting matrix metalloproteases and providing antioxidative activities patent US20120058140A1; 2012.
   Google Scholar
• Khan SB, Kong C-S, Kim J-A, Kim S-K. Protective effect of Amphiroa dilatata on ROS induced oxidative damage and MMP expressions in HT1080 cells. Biotechnol Bioprocess Eng 2010;15:191–8.
   Web of Science ®Google Scholar
• Gupta SK. Bioderm Research, Scottsdale, AZ, USA, assignee. Matrix metalloprotease (MMP) inhibitors and their application in cosmetic and pharmaceutical composition patent US20060074108A1; 2006.
   Google Scholar
• Yoon SO, Park SJ, Yoon SY, et al. Sustained production of H(2)O(2) activates pro-matrix metalloproteinase-2 through receptor tyrosine kinases/phosphatidylinositol 3-kinase/NF-kappa B pathway. J Biol Chem 2002;277:30271–82.
   PubMed Web of Science ®Google Scholar
• Rao BG. Recent developments in the design of specific Matrix Metalloproteinase inhibitors aided by structural and computational studies. Curr Pharm Des 2005;11:295–322.
   PubMed Web of Science ®Google Scholar
• Skiles JW, Gonnella NC, Jeng AY. The design, structure, and therapeutic application of matrix metalloproteinase inhibitors. Curr Med Chem 2001;8:425–74.
   PubMed Web of Science ®Google Scholar
• Campestre C, Agamennone M, Tauro M, Tortorella P. Phosphonate emerging zinc binding group in matrix metalloproteinase inhibitors. Curr Drug Targets 2015;16:1634–44.
   PubMed Web of Science ®Google Scholar
• Giustiniano M, Tortorella P, Agamennone M, et al. Amino acid derivatives as new zinc binding groups for the design of selective matrix metalloproteinase inhibitors. J Amino Acids 2013;178381, 12 p.
   Google Scholar
• Agrawal A, Romero-Perez D, Jacobsen JA, et al. Zinc-binding groups modulate selective inhibition of MMPs. ChemMedChem 2008;3:812–20.
   PubMed Web of Science ®Google Scholar
• Jacobsen FE, Lewis JA, Cohen SM. The design of inhibitors for medicinally relevant metalloproteins. ChemMedChem 2007;2:152–71.
   PubMed Web of Science ®Google Scholar
• Campestre C, Agamennone M, Tortorella P, et al. N-Hydroxyurea as zinc binding group in matrix metalloproteinase inhibition: mode of binding in a complex with MMP-8. Bioorg Med Chem Lett 2006;16:20–4.
   PubMed Web of Science ®Google Scholar
• Yuan H, Lu W, Wang L, et al. Synthesis of derivatives of methyl rosmarinate and their inhibitory activities against matrix metalloproteinase-1 (MMP-1). Eur J Med Chem 2013;62:148–57.
   PubMed Web of Science ®Google Scholar
• Mahmood T, Akhtar N. Combined topical application of lotus and green tea improves facial skin surface parameters. Rejuvenation Res 2013;16:91–7.
   PubMed Web of Science ®Google Scholar
• Kim MS, Oh GH, Kim MJ, Hwang JK. Fucosterol inhibits matrix metalloproteinase expression and promotes type-1 procollagen production in UVB-induced HaCaT cells. Photochem Photobiol 2013;89:911–18.
   PubMed Web of Science ®Google Scholar
• Gweon EJ, Kim SJ. Resveratrol attenuates matrix metalloproteinase-9 and -2-regulated differentiation of HTB94 chondrosarcoma cells through the p38 kinase and JNK pathways. Oncol Rep 2014;32:71–8.
   PubMed Web of Science ®Google Scholar
• Kousidou OC, Mitropoulou TN, Roussidis AE, et al. Genistein suppresses the invasive potential of human breast cancer cells through transcriptional regulation of metalloproteinases and their tissue inhibitors. Int J Oncol 2005;26:1101–9.
   PubMed Web of Science ®Google Scholar
• Ricciarelli R, Maroni P, Ozer N, et al. Age-dependent increase of collagenase expression can be reduced by alpha-tocopherol via protein kinase C inhibition. Free Radic Biol Med 1999;27:729–37.
   PubMed Web of Science ®Google Scholar
• Alleva R, Tomasetti M, Sartini D, et al. alpha-Lipoic acid modulates extracellular matrix and angiogenesis gene expression in non-healing wounds treated with hyperbaric oxygen therapy. Mol Med 2008;14:175–83.
   PubMed Web of Science ®Google Scholar
• Rubino MT, Maggi D, Laghezza A, et al. Identification of novel matrix metalloproteinase inhibitors by screening of phenol fragments library. Arch Pharm (Weinheim, Ger) 2011;344:557–63.
   PubMed Web of Science ®Google Scholar
• Nicolotti O, Catto M, Giangreco I, et al. Design, synthesis and biological evaluation of 5-hydroxy, 5-substituted-pyrimidine-2,4,6-triones as potent inhibitors of gelatinases MMP-2 and MMP-9. Eur J Med Chem 2012;58:368–76.
   PubMed Web of Science ®Google Scholar
• Rubino MT, Agamennone M, Campestre C, et al. Synthesis, SAR, and biological evaluation of alpha-sulfonylphosphonic acids as selective matrix metalloproteinase inhibitors. ChemMedChem 2009;4:352–62.
   PubMed Web of Science ®Google Scholar
• Biasone A, Tortorella P, Campestre C, et al. alpha-Biphenylsulfonylamino 2-methylpropyl phosphonates: enantioselective synthesis and selective inhibition of MMPs. Bioorg Med Chem 2007;15:791–9.
   PubMed Web of Science ®Google Scholar
• Pochetti G, Gavuzzo E, Campestre C, et al. Structural insight into the stereoselective inhibition of MMP-8 by enantiomeric sulfonamide phosphonates. J Med Chem 2006;49:923–31.
   PubMed Web of Science ®Google Scholar
• Mishra KK, Pal RS, Arunkumar R, et al. Antioxidant properties of different edible mushroom species and increased bioconversion efficiency of Pleurotus eryngii using locally available casing materials. Food Chem 2013;138:1557–63.
   PubMed Web of Science ®Google Scholar
• Hummer G. Molecular binding: under water’s influence. Nat Chem 2010;2:906–7.
   PubMed Web of Science ®Google Scholar
• LigPrep version 3.4, Maestro version 10.2, MacroModel, version 10.8, Phase version 4.3, Schrödinger, LLC, New York, NY; 2015.
   Google Scholar
• Lauro G, Tortorella P, Bertamino A, et al. Structure-based design of microsomal prostaglandin E2 synthase-1 (mPGES-1) inhibitors using a virtual fragment growing optimization scheme. ChemMedChem 2016;11:612–19.
   PubMed Web of Science ®Google Scholar
• Mishra K, Ojha H, Chaudhury NK. Estimation of antiradical properties of antioxidants using DPPH[rad] assay: a critical review and results. Food Chem 2012;130:1036–43.
   Web of Science ®Google Scholar
• Sharma OP, Bhat TK. DPPH antioxidant assay revisited. Food Chem 2009;113:1202–5.
   Web of Science ®Google Scholar
• GraphPad Prism-5.0c: GraphPad Software Inc., San Diego, CA; 2009.
   Google Scholar
• Battye TG, Kontogiannis L, Johnson O, et al. iMOSFLM: a new graphical interface for diffraction-image processing with MOSFLM. Acta Crystallogr D Biol Crystallogr 2011;67:271–81.
   PubMedGoogle Scholar
• Navaza J. Amore – an automated package for molecular replacement. Acta Cryst A 1994;50:157–63.
   Web of Science ®Google Scholar
• Pochetti G, Montanari R, Gege C, et al. Extra binding region induced by non-zinc chelating inhibitors into the S1′ subsite of matrix metalloproteinase 8 (MMP-8). J Med Chem 2009;52:1040–9.
   PubMed Web of Science ®Google Scholar
• Brunger AT, Adams PD, Clore GM, et al. Crystallography & NMR system: a new software suite for macromolecular structure determination. Acta Crystallogr D Biol Crystallogr 1998;54:905–21.
   PubMed Web of Science ®Google Scholar
• Rowsell S, Hawtin P, Minshull CA, et al. Crystal structure of human MMP9 in complex with a reverse hydroxamate inhibitor. J Mol Biol 2002;319:173–81.
   PubMed Web of Science ®Google Scholar
• Dhanaraj V, Williams MG, Ye QZ, et al. X-ray structure of gelatinase A catalytic domain complexed with a hydroxamate inhibitor. Croat Chem Acta 1999;72:575–91.
   Web of Science ®Google Scholar